Tenet Healthcare Corporation(THC)

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Latest News & Analysis
Tenet Repricing Inflection: Analyst Upgrades Validate Q3 Margin Thesis
Truist raises target to $240, JPMorgan to $230 post-Q3 earnings. Consensus reprices +9.8% to $229.69 as institutional conviction solidifies around bull-case.
Tenet Healthcare Delivers Margin Durability Proof; Guidance Raise Validates Thesis
Q3 results show 160 bps hospital margin expansion and 26% adjusted EPS growth. Guidance raise validates Conifer AI and USPI momentum thesis.
Tenet Healthcare Faces Critical Margin Test as Q3 Earnings Approach
Leerink upgrade validates USPI momentum ahead of Q3 earnings on October 28, but market hinges on hospital margin durability.
Tenet Healthcare (THC): Q4 Earnings, 2025 Outlook, and Analysis
Tenet Healthcare (THC) exhibits strong Q4 2024 performance, positive 2025 outlook, and favorable analyst ratings, presenting both opportunities and risks.
Tenet Healthcare (THC): Analyzing Market Trends, Earnings Outlook, and Growth Strategy
Tenet Healthcare (THC) is a trending stock attracting investor attention. Analysis suggests a strong value stock with earnings potential, driven by USPI growth and expense management.
Tenet Healthcare (THC) Financial Performance and Outpatient Strategy Analysis
Tenet Healthcare (THC) reported a significant Q1 2025 earnings beat, driving stock momentum. Analysis explores financials, outpatient strategy, policy impacts, and growth prospects.
Tenet Healthcare Corporation (THC) Q1 2025 Earnings Beat and Strategic Growth Analysis
Tenet Healthcare (THC) delivers strong Q1 2025 earnings beat driven by ambulatory care growth, strategic hospital divestitures, and operational efficiencies.
Tenet Healthcare Corporation (THC) Strategic Shift and Financial Resilience Drive Growth
Tenet Healthcare's strategic pivot to ambulatory care, USPI expansion, and hospital divestitures bolster profitability and financial health ahead of Q2 2025 earnings.
Tenet Healthcare (THC) Q2 2025 Earnings Preview and Strategic Financial Analysis
Detailed analysis of Tenet Healthcare's Q2 2025 earnings outlook, strategic portfolio shift, financial metrics, and competitive positioning in healthcare sector.
Tenet Healthcare (THC) Q2 2025 Surge and Strategic Shift Amid Medicaid Policy Changes
Tenet Healthcare's strong Q2 2025 earnings driven by ambulatory care growth, raised guidance, and strategic positioning against post-2026 Medicaid policy shifts.
Tenet Healthcare (THC): Cash, Buybacks and the Ambulatory Pivot
Tenet’s shares trade at **$179.60** with a **$15.87B** market cap as management leans on free cash flow, buybacks and ambulatory expansion after Q2 2025 results.
Tenet Healthcare (THC): Cash, USPI, and the Numbers Behind Recent Earnings Beats
After a string of outsized earnings beats and stronger free cash flow in 2024, Tenet (THC) shows pronounced margin improvement but data inconsistencies and heavy M&A make the financing picture complex.